Cryoport (CYRX) Misses Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Cryoport Revenue Grows 59% for Second Quarter 2018; 73% in Biopharma
August 9, 2018 4:10 PM EDTIRVINE, Calif., Aug. 9, 2018 /PRNewswire/ --Â Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) ("Cryoport" or the "Company"), the world's leading temperature-controlled logistics company dedicated to the life sciences industry, today announced financial results for the three and six-month periods ended June 30, 2018.
"This was another strong quarter for Cryoport, as revenues from clinical support programs and the ongoing ramp from... More
